These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36324154)

  • 1. The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis.
    Feng Y; Li W; Wang Z; Zhang R; Li Y; Zang L; Wang P; Li Z; Dong Y
    J Transl Med; 2022 Nov; 20(1):497. PubMed ID: 36324154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression.
    Wang G; Duan J; Pu G; Ye C; Li Y; Xiu W; Xu J; Liu B; Zhu Y; Wang C
    Biochim Biophys Acta Mol Basis Dis; 2022 Aug; 1868(8):166413. PubMed ID: 35413401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis.
    Zhu Y; Zhao H; Lu J; Lin K; Ni J; Wu G; Tang H
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):653-664. PubMed ID: 33894425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis.
    Ran S; Song L; Yang H; Yu J; Zhen Y; Liu Q
    PLoS One; 2024; 19(3):e0301133. PubMed ID: 38547097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis.
    Lei Z; Yu J; Wu Y; Shen J; Lin S; Xue W; Mao C; Tang R; Sun H; Qi X; Wang X; Xu L; Wei C; Wang X; Chen H; Hao P; Yin W; Zhu J; Li Y; Wu Y; Liu S; Liang H; Chen X; Su C; Zhou S
    J Hepatol; 2024 Feb; 80(2):194-208. PubMed ID: 38438948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis.
    Koh EH; Yoon JE; Ko MS; Leem J; Yun JY; Hong CH; Cho YK; Lee SE; Jang JE; Baek JY; Yoo HJ; Kim SJ; Sung CO; Lim JS; Jeong WI; Back SH; Baek IJ; Torres S; Solsona-Vilarrasa E; Conde de la Rosa L; Garcia-Ruiz C; Feldstein AE; Fernandez-Checa JC; Lee KU
    Gut; 2021 Oct; 70(10):1954-1964. PubMed ID: 33208407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOSL2 deficiency delays nonalcoholic steatohepatitis progression by regulating LY6D-mediated NLRP3 activation.
    Hu PX; Sheng MY; Liu YP; Zhang CQ
    Hum Cell; 2022 Nov; 35(6):1752-1765. PubMed ID: 35930135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease.
    Jiao J; Sanchez JI; Saldarriaga OA; Solis LM; Tweardy DJ; Maru DM; Stevenson HL; Beretta L
    JHEP Rep; 2023 Feb; 5(2):100628. PubMed ID: 36687470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.
    Machado MV; Michelotti GA; Pereira Tde A; Boursier J; Kruger L; Swiderska-Syn M; Karaca G; Xie G; Guy CD; Bohinc B; Lindblom KR; Johnson E; Kornbluth S; Diehl AM
    Gut; 2015 Jul; 64(7):1148-57. PubMed ID: 25053716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.
    Wang X; Zheng Z; Caviglia JM; Corey KE; Herfel TM; Cai B; Masia R; Chung RT; Lefkowitch JH; Schwabe RF; Tabas I
    Cell Metab; 2016 Dec; 24(6):848-862. PubMed ID: 28068223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
    Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
    J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis.
    Harrison SA; Goodman Z; Jabbar A; Vemulapalli R; Younes ZH; Freilich B; Sheikh MY; Schattenberg JM; Kayali Z; Zivony A; Sheikh A; Garcia-Samaniego J; Satapathy SK; Therapondos G; Mena E; Schuppan D; Robinson J; Chan JL; Hagerty DT; Sanyal AJ
    J Hepatol; 2020 May; 72(5):816-827. PubMed ID: 31887369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis.
    Goto T; Itoh M; Suganami T; Kanai S; Shirakawa I; Sakai T; Asakawa M; Yoneyama T; Kai T; Ogawa Y
    Sci Rep; 2018 May; 8(1):8157. PubMed ID: 29802399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis
    Zhang T; Zhou Y; Zhang Y; Wang DG; Lv QY; Wang W; Bai YP; Hua Q; Guo LQ
    Front Pharmacol; 2024; 15():1347274. PubMed ID: 38362146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis.
    Shi H; Wang X; Li F; Gerlach BD; Yurdagul A; Moore MP; Zeldin S; Zhang H; Cai B; Zheng Z; Valenti L; Tabas I
    Sci Transl Med; 2022 Nov; 14(672):eabp8309. PubMed ID: 36417485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin improved hepatic injury of NASH by regulating NRF2/HO-1/NRLP3 pathway.
    Shi H; Qiao F; Lu W; Huang K; Wen Y; Ye L; Chen Y
    Eur J Pharmacol; 2022 Nov; 934():175270. PubMed ID: 36184988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MIR22HG/microRNA-9-3p/IGF1 in nonalcoholic steatohepatitis, the ceRNA network increases fibrosis by inhibiting autophagy and promoting pyroptosis.
    Chen X; Zhou S; Chen Y; Tong K; Huang W
    Clin Nutr; 2024 Jan; 43(1):52-64. PubMed ID: 38011754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
    J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.